Hormone replacement therapy may be good for your heart

Image
IANS New York
Last Updated : Mar 09 2017 | 2:57 PM IST

Women using hormone replacement therapy to relieve the symptoms of menopause may have improved heart health and better survival rates, a study has found.

The finding showed that women using hormone replacement therapy were overall 30 per cent less likely to die than those not on hormone therapy.

Further, such women were also 20 per cent more likely to have a coronary calcium score of zero -- the lowest possible score, indicating a low likelihood of heart attack -- and 36 per cent less likely to have a coronary calcium score above 399 -- indicative of severe atherosclerosis and high heart attack risk.

"Hormone replacement therapy resulted in lower atherosclerosis and improved survival for all age groups and for all levels of coronary calcium," said lead author Yoav Arnson, postdoctoral scientist at Cedars-Sinai Medical Center -- a non-profit hospital in California, US.

The results will be presented at the American College of Cardiology's 66th Annual Scientific Session in Washington.

Hormone replacement therapy -- which involves the use of supplemental oestrogen, sometimes along with progesterone or similar hormones -- lowered the levels of atherosclerosis -- plaque buildup in the heart's arteries -- as well as the risk of death.

Oestrogen protects heart health through its beneficial effects on cholesterol and because it increases the flexibility of blood vessels and arteries, allowing them to accommodate blood flow, the researchers said.

Oestrogen levels usually tend to plummet after menopause and thus increase the rates of heart disease in women.

By replacing the natural estrogen lost during menopause, hormone replacement therapy could be one way for women to regain the cardiovascular benefits of estrogen, Arnson said.

Thus, "with proper screening and proper follow-up, it is beneficial to take hormone replacement therapy", Arnson added.

However, women who have already had a heart attack, have known heart disease or have a history of blood clots are advised against taking hormone replacement therapy, the researchers noted.

--IANS

rt/sm/dg

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Mar 09 2017 | 2:46 PM IST

Next Story